breakthroughs
- A finding at the La Jolla Institute for Allergy & Immunology has major implications for the development of a first-ever vaccine against dengue virus. Sujan Shresta, Ph.D, led the research team. Learn More
- Discovery of an enzyme's previously unknown role as a tumor suppressor that may be important in myeloproliferative diseases and some types of lymphoma and leukemia. Toshiaki Kawakami, M.D., Ph.D., led the research team. Learn More
- More Breakthroughs
research
- Center for Infectious Disease - dengue virus, smallpox, hepatitis C, and emerging biothreats like SARS and more.
- Type 1 Diabetes Center - accelerating the path to find a safe prevention and cure for type 1 (juvenile) diabetes.
- Allergy & Asthma - controlling life-altering or life-threatening reactions.
- Autoimmune Diseases - diabetes, inflammatory bowel disease, rheumatoid arthritis and more.
- Cancer Research - lymphomas & leukemias, apoptosis & cell death, stimulating immune responses against tumors and more.
- Inflammation Biology - coronary artery disease and lung disease.
- Microbiology and Immunology - inextricably linked in the study of infectious diseases.
seminars and events
- Joel Ernst, "The Immunological Life Cycle of Tuberculosis", Wednesday, 09/08/10: 12:00 PM
- David Nemazee, "Genetic and biochemical analysis of B cell tolerance", Wednesday, 09/15/10: 12:00 PM
- View all seminars and conferences
news
- 8/26/2010 - Rancho Santa Fe Review
New Board Chairman Aims to Raise Awareness of
LIAI's Work Combating Infectious and Autoimmune Diseases
John E. Major, Interviewed
Article link | .pdf - 8/19/2010 - Rancho Santa Fe Review
La Jolla Institute Probes Mysteries of the Human Immune System
Mitchell Kronenberg, Ph.D. Interviewed
Article link | .pdf - 7/30/2010 - KPBS Radio
Public Urged To Get Whooping Cough Vaccine
Shane Crotty, Ph.D. Interviewed
Audio link | Radio link - More News
- Information on The La Jolla Institute
